Development of Dual Language (Urdu and English) Digital Software For Self- Assessment And Management Of Adult Dysarthria Patients
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- Frenchay Dysarthria Assessment (FDA-2)
研究概览
简要总结
The research focuses on the development of a dual-language (Urdu and English) digital software designed for the self-assessment and management of adult dysarthria patients. Dysarthria, a motor speech disorder resulting from neurological injury, significantly affects an individual's ability to communicate effectively.
详细描述
Current assessment tools are often clinician-dependent and predominantly available in English, limiting accessibility for non-English speakers, especially in Pakistan and other Urdu-speaking regions. This study aims to bridge that gap by creating a user-friendly, culturally relevant, and linguistically accessible software platform. The software will enable adult dysarthric patients to monitor their speech abilities, track progress, and participate more actively in their therapy process. It is expected to enhance patient autonomy, improve communication outcomes, and support speech-language pathologists in delivering more efficient care. The dual-language interface ensures broader usability, promoting inclusion and better engagement among diverse user groups in bilingual settings.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adults (18+) diagnosed with dysarthria due to neurological causes (e.g., stroke, Parkinson's).
- •Able to understand and communicate in Urdu and/or English.
- •Cognitive ability sufficient to use digital tools for self-assessment.
- •Consent to participate in the study.
排除标准
- •Severe cognitive impairment or dementia limiting participation.
- •Co-existing speech disorders unrelated to dysarthria (e.g., aphasia).
- •Hearing impairments that prevent use of audio-based software.
- •Unwillingness or inability to use digital devices.
结局指标
主要结局
Frenchay Dysarthria Assessment (FDA-2)
时间窗: 24 Months
Assesses: Motor speech function. Scoring: A (normal) to E (severely impaired) across speech subsystems.
Dysarthria Impact Profile (DIP)
时间窗: 24 Months
Assesses: Psychosocial impact of dysarthria. Scoring: 48 items, rated 1-5; higher scores = greater negative impact.
Speech Intelligibility Rating Scale (SIRS)
时间窗: 24 Months
Assesses: Speech clarity. Scoring: 1 (unintelligible) to 5 (fully intelligible).
Voice Handicap Index-10 (VHI-10) (optional)
时间窗: 24 Months
Assesses: Patient's perception of voice issues. Scoring: 0-4 per item; total out of 40. Higher = more voice difficulty.
次要结局
未报告次要终点
研究者
Muhammad Naveed Babur
Principal Investigator
Superior University
